Efficacy and safety of phospholipid nanoparticles (VBI-S) in reversing intractable hypotension in patients with septic shock: a multicentre, open-label, repeated measures, phase 2a clinical pilot trial

Cuthbert Simpkins, Michael Moncure, Heather Klepacz, Kristopher Roach, Sadia Benzaquen, Luis Diaz-Caballero, Jonathan Cohen, Daniel Haase, Mukesh Kumar, Harven DeShield, Anthony Manasia, Juan Rodriguez, Prashanth Anamthathmakula, Nik Hurt, Bhaswati Mukherjee, Krishna Talluri

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number102430
JournaleClinicalMedicine
Volume68
DOIs
StatePublished - Feb 2024
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • Hypotension
  • Multiple organ dysfunction syndrome
  • Nitric oxide
  • Phospholipid nanoparticles
  • Sepsis

Cite this